ReviewImmunotherapy2025

Chimeric antigen receptor natural killer (CAR-NK) cells: from preclinical promise to clinical reality in cancer immunotherapy.

Hunter Cassidy Cochran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.